TREM2 is associated with tumor immunity and implies poor prognosis in glioma

Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in myeloid cells of the central nervous system (CNS), which mediate the immunological response in a variety of diseases. Uncertain is the function of TREM2 in glioma and tumor immune responses. In this research, the expression pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Mingchen, Chang, Yuanhao, Zhai, You, Pang, Bo, Wang, Peng, Li, Guanzhang, Jiang, Tao, Zeng, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874686/
https://www.ncbi.nlm.nih.gov/pubmed/36713360
http://dx.doi.org/10.3389/fimmu.2022.1089266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874686/
https://www.ncbi.nlm.nih.gov/pubmed/36713360
http://dx.doi.org/10.3389/fimmu.2022.1089266

Ejemplares similares